This company has shut down. Akoya Biosciences is no longer operating — its last tracked round was a Post-IPO Equity in 2023.
Explore the Startup GraveyardAkoya Biosciences is a spatial biology company offering solutions for high-parameter tissue analysis from biomarker discovery to validation.
Akoya Biosciences has raised $43.5M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in June 2023.
Akoya Biosciences's investors include Piper Jaffray Merchant Banking, Telegraph Hill Partners, Innovatus Capital Partners, Thomas Schnettler.
Akoya Biosciences is headquartered in Marlborough, United States.
Akoya Biosciences is a spatial biology company offering solutions for high-parameter tissue analysis from biomarker discovery to validation.
Akoya Biosciences is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Akoya Biosciences — Funding & Investors." VCBacked, June 7, 2023, https://www.vcbacked.co/company/akoya-biosciences. Accessed August 14, 2026.
VCBacked. (2023). Akoya Biosciences — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/akoya-biosciences
{{cite web |title=Akoya Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/akoya-biosciences |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated